Grants Relating to Diabetes and Hypoglycaemia
- HyperCheat – CHI to T1DM Technology Translation Feasibility Study – March 2024 to July 2024; Pankhurst Seedcorn Funding; £13,874 + £7,000(DA Costs);
- HYPO-CHEAT: prospective data-driven hypoglycaemia reduction in the rare disease of Congenital Hyperinsulinism – Jan 2024 to Jan 2025; MRC/Wellcome Trust C4T ; £74,548 + £34,693(DA Costs);
- Hypoglycemia T1DM–NICE Accelerator – Nov 2023 to Oct 2024; MRC A2E; £23,084 + £10127.80(DA Costs);
- HypoCheat Clinical Trial Accelerator – Nov 2022 to Oct 2023; Wellcome Trust A2E; £24,025 + £14840.86(DA Costs);
- Melontech Startup (pivot to Type 1) – Sept 2020 (Ongoing); University of Manchester Innovation Factory UOMIF investment £20,000;